BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38566493)

  • 1. Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study.
    Plaisy MK; Minga AK; Wandeler G; Murenzi G; Samala N; Ross J; Lopez A; Mensah E; de Waal R; Kuniholm MH; Diero L; Salvi S; Moreira R; Attia A; Mandiriri A; Shumbusho F; Goodrich S; Rupasinghe D; Alarcon P; Maruri F; Perrazo H; Jaquet A;
    J Int AIDS Soc; 2024 Apr; 27(4):e26238. PubMed ID: 38566493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.
    Perazzo H; Cardoso SW; Yanavich C; Nunes EP; Morata M; Gorni N; da Silva PS; Cardoso C; Almeida C; Luz P; Veloso VG; Grinsztejn B
    J Int AIDS Soc; 2018 Nov; 21(11):e25201. PubMed ID: 30394678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cardiovascular risk factors by HIV status in a population-based cohort in South Central Uganda: a cross-sectional survey.
    Enriquez R; Ssekubugu R; Ndyanabo A; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekstrom AM; Sewankambo NK; Serwadda DM; Nordenstedt H
    J Int AIDS Soc; 2022 Apr; 25(4):e25901. PubMed ID: 35419976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
    Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
    AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia.
    Chihota BV; Riebensahm C; Muula G; Sinkala E; Chilengi R; Mulenga L; Bosomprah S; Vinikoor MJ; Bolton-Moore C; Egger M; Rauch A; Berzigotti A; Wandeler G;
    BMJ Open Gastroenterol; 2022 Jul; 9(1):. PubMed ID: 35831020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.
    Ciardullo S; Monti T; Perseghin G
    Diabetes Care; 2021 Feb; 44(2):519-525. PubMed ID: 33303638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    Milic J; Menozzi V; Schepis F; Malagoli A; Besutti G; Franconi I; Raimondi A; Carli F; Mussini C; Sebastiani G; Guaraldi G
    AIDS; 2020 Nov; 34(13):1915-1921. PubMed ID: 33009010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
    Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
    Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.
    Long MT; Zhang X; Xu H; Liu CT; Corey KE; Chung RT; Loomba R; Benjamin EJ
    Hepatology; 2021 Feb; 73(2):548-559. PubMed ID: 33125745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
    Demir M; Deyneli O; Yılmaz Y
    Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
    Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA;
    HIV Med; 2024 Jan; 25(1):95-106. PubMed ID: 37670375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment-A Cross-sectional Study.
    van Eekeren LE; Vadaq N; Vos WAJW; Blaauw MJT; Groenendijk AL; van Lunzen J; Stalenhoef JE; Berrevoets MAH; Verbon A; Weijers G; Netea MG; van der Ven AJAM; de Mast Q; Joosten LAB; Tjwa ETTL
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae266. PubMed ID: 38868310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    Zhang X; Heredia NI; Balakrishnan M; Thrift AP
    PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease.
    Zhang W; Song WJ; Chen W; Pan Z; Zhang J; Fan L; Li J
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):802-810. PubMed ID: 38526946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite prospective Liver Disease and Reproductive Ageing (LIVRA) study in US women living with and without HIV.
    Price J; Ma Y; Adimora A; Fischl M; French AL; Golub ET; Konkle-Parker D; Kuniholm MH; Ofotokun I; Plankey M; Sharma A; Tien PC
    BMJ Open; 2022 Apr; 12(4):e055706. PubMed ID: 35393310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.